Frontlight ResearchEarly access
Trial site
Giromed Institute S.L.P.
- 2running trials
- 12closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Asthma9 trials
- COPD3 trials
- Idiopathic pulmonary fibrosis2 trials
- Phase
- Phase 37 trials
- Phase 26 trials
- Phase 2/31 trial
- Status
- Completed12 trials
- Active, not recruiting2 trials
- Lead sponsor
- AstraZeneca4 trials
- Chiesi Farmaceutici S.p.A.2 trials
- Sanofi2 trials
- Upstream Bio Inc.2 trials
- GlaxoSmithKline1 trial
- and 3 more
Running trials
Closed trials
Completed
Completed
Completed
Completed
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
Completed
Completed
Completed
Completed
Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma
Completed
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026